Abstract
Purpose
Androgen insensitivity syndrome (AIS) is a disorder characterized by peripheral androgen resistance due to androgen receptor mutations in subjects with 46 XY karyotype. The severity of hormone resistance (complete, partial or mild) determines the wide spectrum of phenotypes.
Methods
We performed a literature review on Pubmed focusing on etiopathogenesis, molecular alterations, and diagnostic-therapeutic management.
Results
AIS is determined by a large variety of X-linked mutations that account for the wide phenotypic spectrum of subjects; it represents one of the most frequent disorders of sexual development (DSD). Clinical suspicion can arise at birth in partial AIS, due to the presence of variable degrees of ambiguity of the external genitalia, and at pubertal age in complete AIS, due to the development of female secondary sex characteristics, primary amenorrhea, and absence of female primary sex characteristics (uterus and ovaries). Laboratory tests showing elevated LH and testosterone levels despite mild or absent virilization may be helpful, but diagnosis can be achieved only after genetic testing (karyotype examination and androgen receptor sequencing). The clinical phenotype and especially the decision on sex assignment of the patient, if the diagnosis is made at birth or in the neonatal period, will guide the following medical, surgical and psychological management.
Conclusions
For the management of AIS, a multidisciplinary team consisting of physicians, surgeons, and psychologists is highly recommended to support the patient and his/her family on gender identity choices and subsequent appropriate therapeutic decisions.
Similar content being viewed by others
Availability of data and material
No data or material to share.
Code availability
No code to share.
References
Hughes IA, Houk C, Ahmed SF, Lee PA, LWPES Consensus Group, ESPE Consensus Group (2006) Consensus statement on management of intersex disorders. Arch Dis Child 91(7):554–563. https://doi.org/10.1136/adc.2006.098319
Hughes IA, Davies JD, Bunch TI, Pasterski V, Mastroyannopoulou K, MacDougall J (2012) Androgen insensitivity syndrome. Lancet 380(9851):1419–1428. https://doi.org/10.1016/S0140-6736(12)60071-3
Bertelloni S, Dati E, Baroncelli GI, Hiort O (2011) Hormonal management of complete androgen insensitivity syndrome from adolescence onward. Horm Res Paediatr 76(6):428–433. https://doi.org/10.1159/000334162
Berglund A, Johannsen TH, Stochholm K, Viuff MH, Fedder J, Main KM, Gravholt CH (2016) Incidence, prevalence, diagnostic delay, and clinical presentation of female 46, XY disorders of sex development. J Clin Endocrinol Metab 101(12):4532–4540. https://doi.org/10.1210/jc.2016-2248
Boehmer AL, Brinkmann O, Brüggenwirth H, van Assendelft C, Otten BJ, Verleun-Mooijman MC, Niermeijer MF, Brunner HG, Rouwé CW, Waelkens JJ, Oostdijk W, Kleijer WJ, van der Kwast TH, de Vroede MA, Drop SL (2001) Genotype versus phenotype in families with androgen insensitivity syndrome. J Clin Endocrinol Metab 86(9):4151–4160. https://doi.org/10.1210/jcem.86.9.7825
Quigley CA, De Bellis A, Marschke KB, el-Awady MK, Wilson EM, French FS (1995) Androgen receptor defects: historical, clinical, and molecular perspectives. Endocr Rev 16(3):271–321. https://doi.org/10.1210/edrv-16-3-271
Bhandari RK, Haque MM, Skinner MK (2012) Global genome analysis of the downstream binding targets of testis determining factor SRY and SOX9. PLoS ONE 7(9):e43380. https://doi.org/10.1371/journal.pone.0043380. (Epub 2012 Sep 12)
Sekido R, Lovell-Badge R (2008) Sex determination involves synergistic action of SRY and SF1 on a specific Sox9 enhancer. Nature 453(7197):930–934. https://doi.org/10.1038/nature06944. (Epub 2008 May 4. Erratum in: Nature. 2008 Dec 11;456(7223):824)
Ostrer H, Huang HY, Masch RJ, Shapiro E (2007) A cellular study of human testis development. Sex Dev 1(5):286–292. https://doi.org/10.1159/000108930
Pellegrino M, Maiorino R, Schonauer S (2010) WNT4 signaling in female gonadal development. Endocr Metab Immune Disord Drug Targets 10(2):168–174. https://doi.org/10.2174/187153010791213074
Nassar GN, Leslie SW (2023) Physiology, Testosterone. 2023 Jan 2. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing
Reyes FI, Boroditsky RS, Winter JS, Faiman C (1974) Studies on human sexual development. II. Fetal and maternal serum gonadotropin and sex steroid concentrations. J Clin Endocrinol Metab 38(4):612–617. https://doi.org/10.1210/jcem-38-4-612
Nagamani M, McDonough PG, Ellegood JO, Mahesh VB (1979) Maternal and amniotic fluid steroids throughout human pregnancy. Am J Obstet Gynecol 134(6):674–680. https://doi.org/10.1016/0002-9378(79)90649-5
Winter JS, Hughes IA, Reyes FI, Faiman C (1976) Pituitary-gonadal relations in infancy: 2. Patterns of serum gonadal steroid concentrations in man from birth to two years of age. J Clin Endocrinol Metab 42(4):679–686. https://doi.org/10.1210/jcem-42-4-679
Kuiri-Hänninen T, Sankilampi U, Dunkel L (2014) Activation of the hypothalamic-pituitary-gonadal axis in infancy: minipuberty. Horm Res Paediatr 82(2):73–80. https://doi.org/10.1159/000362414
Bakker J, Brock O (2010) Early oestrogens in shaping reproductive networks: evidence for a potential organisational role of estradiol in female brain development. J Neuroendocrinol 22(7):728–735. https://doi.org/10.1111/j.1365-2826.2010.02016.x
Arnold AP, Xu J, Grisham W, Chen X, Kim YH, Itoh Y (2004) Minireview: sex chromosomes and brain sexual differentiation. Endocrinology 145(3):1057–1062. https://doi.org/10.1210/en.2003-1491
Masica DN, Money J, Ehrhardt AA (1971) Fetal feminization and female gender identity in the testicular feminizing syndrome of androgen insensitivity. Arch Sex Behav 1(2):131–142. https://doi.org/10.1007/BF01541057
Hines M, Ahmed SF, Hughes IA (2003) Psychological outcomes and gender-related development in complete androgen insensitivity syndrome. Arch Sex Behav 32(2):93–101. https://doi.org/10.1023/a:1022492106974
T’Sjoen G, De Cuypere G, Monstrey S, Hoebeke P, Freedman FK, Appari M, Holterhus PM, Van Borsel J, Cools M (2011) Male gender identity in complete androgen insensitivity syndrome. Arch Sex Behav 40(3):635–638. https://doi.org/10.1007/s10508-010-9624-1
Brunner F, Fliegner M, Krupp K, Rall K, Brucker S, Richter-Appelt H (2016) Gender role, gender identity and sexual orientation in CAIS (“XY-Women”) compared with subfertile and infertile 46,XX Women. J Sex Res 53(1):109–124. https://doi.org/10.1080/00224499.2014.1002124
Savic I, Frisen L, Manzouri A, Nordenstrom A, Lindén Hirschberg A (2017) Role of testosterone and Y chromosome genes for the masculinization of the human brain. Hum Brain Mapp 38(4):1801–1814. https://doi.org/10.1002/hbm.23483
Gottlieb B, Beitel LK, Nadarajah A, Paliouras M, Trifiro M (2012) The androgen receptor gene mutations database: 2012 update. Hum Mutat 33(5):887–894. https://doi.org/10.1002/humu.22046. (Epub 2012 Mar 13)
Zhou D, Xu H, Shen X, Gu R, Chen Y, Chen G, Li P, Shi H, Sun X, Xin A (2022) Complete androgen insensitivity syndrome caused by a novel mutation in the androgen receptor gene and its mechanism. Clin Chim Acta 531:94–99. https://doi.org/10.1016/j.cca.2022.03.021
Chen G, Zhao D, Zhu L, Zhao Y, Zhang J, Wang X, Tian H, Tang D, Shu Q, Qiao S (2022) Novel androgen receptor gene variant containing a frameshift mutation in a patient with complete androgen insensitivity syndrome. Andrologia 54(2):e14292. https://doi.org/10.1111/and.14292
Zhang D, Yao F, Tian T, Deng S, Luo M, Tian Q (2021) Clinical characteristics and molecular genetics of complete androgen insensitivity syndrome patients: a series study of 30 cases from a Chinese tertiary medical center. Fertil Steril 115(5):1270–1279. https://doi.org/10.1016/j.fertnstert.2020.12.008
De Conti L, Baralle M, Buratti E (2013) Exon and intron definition in pre-mRNA splicing. Wiley Interdiscip Rev RNA 4(1):49–60. https://doi.org/10.1002/wrna.1140
Batista RL, Rodrigues AS, Nishi MY, Feitosa ACR, Gomes NLRA, Junior JAF, Domenice S, Costa EMF, de Mendonça BB (2017) Heterozygous nonsense mutation in the androgen receptor gene associated with partial androgen insensitivity syndrome in an individual with 47,XXY Karyotype. Sex Dev 11(2):78–81. https://doi.org/10.1159/000468957
Hornig NC, Holterhus PM (2021) Molecular basis of androgen insensitivity syndromes. Mol Cell Endocrinol 523:111146. https://doi.org/10.1016/j.mce.2020.111146
Hughes IA, Werner R, Bunch T, Hiort O (2012) Androgen insensitivity syndrome. Semin Reprod Med 30(5):432–442. https://doi.org/10.1055/s-0032-1324728
Cools M, Drop SL, Wolffenbuttel KP, Oosterhuis JW, Looijenga LH (2006) Germ cell tumors in the intersex gonad: old paths, new directions, moving frontiers. Endocr Rev 27(5):468–484. https://doi.org/10.1210/er.2006-0005
Bouvattier C, Carel JC, Lecointre C, David A, Sultan C, Bertrand AM, Morel Y, Chaussain JL (2002) Postnatal changes of T, LH, and FSH in 46, XY infants with mutations in the AR gene. J Clin Endocrinol Metab 87(1):29–32. https://doi.org/10.1210/jcem.87.1.7923
Hellmann P, Christiansen P, Johannsen TH, Main KM, Duno M, Juul A (2012) Male patients with partial androgen insensitivity syndrome: a longitudinal follow-up of growth, reproductive hormones and the development of gynaecomastia. Arch Dis Child 97(5):403–409. https://doi.org/10.1136/archdischild-2011-300584
Griffin JE, Edwards C, Madden JD, Harrod MJ, Wilson JD (1976) Congenital absence of the vagina. The Mayer-Rokitansky-Kuster-Hauser syndrome. Ann Intern Med 85(2):224–236. https://doi.org/10.7326/0003-4819-85-2-224
Singh S, Ilyayeva S (2022) Androgen Insensitivity Syndrome (2022) In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan–. PMID: 31194363.
Savage MO, Chaussain JL, Evain D, Roger M, Canlorbe P, Job JC (1978) Endocrine studies in male pseudohermaphroditism in childhood and adolescence. Clin Endocrinol (Oxf) 8(3):219–231. https://doi.org/10.1111/j.1365-2265.1978.tb01498.x
Han B, Zhu H, Yao H, Ren J, O’Day P, Wang H, Zhu W, Cheng T, Auchus RJ, Qiao J (2022) Differences of adrenal-derived androgens in 5α-reductase deficiency versus androgen insensitivity syndrome. Clin Transl Sci 15(3):658–666. https://doi.org/10.1111/cts.13184
Dahiya S, Singh M, Mandal S, Jain SL, Rathore A, Lal P (2022) Androgen insensitivity syndrome: can cytology help? Cytopathology 33(2):249–252. https://doi.org/10.1111/cyt.13064
Hannema SE, Scott IS, Rajpert-De Meyts E, Skakkebaek NE, Coleman N, Hughes IA (2006) Testicular development in the complete androgen insensitivity syndrome. J Pathol 208(4):518–527. https://doi.org/10.1002/path.1890
Birnbaum W, Bertelloni S (2014) Sex hormone replacement in disorders of sex development. Endocr Dev 27:149–159. https://doi.org/10.1159/000363640
Birnbaum W, Marshall L, Werner R, Kulle A, Holterhus PM, Rall K, Köhler B, Richter-Unruh A, Hartmann MF, Wudy SA, Auer MK, Lux A, Kropf S, Hiort O (2018) Oestrogen versus androgen in hormone-replacement therapy for complete androgen insensitivity syndrome: a multicentre, randomised, double-dummy, double-blind crossover trial. Lancet Diabetes Endocrinol 6(10):771–780. https://doi.org/10.1016/S2213-8587(18)30197-9
Reddy DS (2004) Testosterone modulation of seizure susceptibility is mediated by neurosteroids 3alpha-androstanediol and 17beta-estradiol. Neuroscience 129(1):195–207. https://doi.org/10.1016/j.neuroscience.2004.08.002
Auer MK, Birnbaum W, Hartmann MF, Holterhus PM, Kulle A, Lux A, Marshall L, Rall K, Richter-Unruh A, Werner R, Wudy SA, Hiort O (2022) Metabolic effects of estradiol versus testosterone in complete androgen insensitivity syndrome. Endocrine 76(3):722–732. https://doi.org/10.1007/s12020-022-03017-8
Poujol N, Lobaccaro JM, Chiche L, Lumbroso S, Sultan C (1997) Functional and structural analysis of R607Q and R608K androgen receptor substitutions associated with male breast cancer. Mol Cell Endocrinol 130(1–2):43–51. https://doi.org/10.1016/s0303-7207(97)00072-5
Amies Oelschlager AM, Debiec K (2019) Vaginal dilator therapy: a guide for providers for assessing readiness and supporting patients through the process successfully. J Pediatr Adolesc Gynecol 32(4):354–358. https://doi.org/10.1016/j.jpag.2019.05.002
Levin HS (2000) Tumors of the testis in intersex syndromes. Urol Clin North Am 27(3):543–551. https://doi.org/10.1016/s0094-0143(05)70101-4
Rajpert-de Meyts E, Hoei-Hansen CE (2007) From gonocytes to testicular cancer: the role of impaired gonadal development. Ann N Y Acad Sci 1120:168–180. https://doi.org/10.1196/annals.1411.013
Deans R, Creighton SM, Liao LM, Conway GS (2012) Timing of gonadectomy in adult women with complete androgen insensitivity syndrome (CAIS): patient preferences and clinical evidence. Clin Endocrinol (Oxf) 76(6):894–898. https://doi.org/10.1111/j.1365-2265.2012.04330.x
Barros BA, Oliveira LR, Surur CRC, Barros-Filho AA, Maciel-Guerra AT, Guerra-Junior G (2021) Complete androgen insensitivity syndrome and risk of gonadal malignancy: systematic review. Ann Pediatr Endocrinol Metab 26(1):19–23. https://doi.org/10.6065/apem.2040170.085
Cheikhelard A, Morel Y, Thibaud E, Lortat-Jacob S, Jaubert F, Polak M, Nihoul-Fekete C (2008) Long-term followup and comparison between genotype and phenotype in 29 cases of complete androgen insensitivity syndrome. J Urol 180(4):1496–1501. https://doi.org/10.1016/j.juro.2008.06.045
Coutant R, de Casson FB, Rouleau S, Douay O, Mathieu E, Gatelais F, Bouhours-Nouet N, Voinot C, Audran M, Limal JM (2004) Divergent effect of endogenous and exogenous sex steroids on the insulin-like growth factor I response to growth hormone in short normal adolescents. J Clin Endocrinol Metab 89(12):6185–6192. https://doi.org/10.1210/jc.2004-0814
Perry RJ, Farquharson C, Ahmed SF (2008) The role of sex steroids in controlling pubertal growth. Clin Endocrinol (Oxf) 68(1):4–15. https://doi.org/10.1111/j.1365-2265.2007.02960.x
Ferlin A, Selice R, Carraro U, Foresta C (2013) Testicular function and bone metabolism–beyond testosterone. Nat Rev Endocrinol 9(9):548–554. https://doi.org/10.1038/nrendo.2013.135
Döhnert U, Wünsch L, Hiort O (2017) Gonadectomy in complete androgen insensitivity syndrome: why and when? Sex Dev 11(4):171–174. https://doi.org/10.1159/000478082
Tack LJW, Maris E, Looijenga LHJ, Hannema SE, Audi L, Köhler B, Holterhus PM, Riedl S, Wisniewski A, Flück CE, Davies JH, T’Sjoen G, Lucas-Herald AK, Evliyaoglu O, Krone N, Iotova V, Marginean O, Balsamo A, Verkauskas G, Weintrob N, Ellaithi M, Nordenström A, Verrijn Stuart A, Kluivers KB, Wolffenbuttel KP, Ahmed SF, Cools M (2018) Management of gonads in adults with androgen insensitivity: an international survey. Horm Res Paediatr 90(4):236–246. https://doi.org/10.1159/000493645
Lucas-Herald A, Bertelloni S, Juul A, Bryce J, Jiang J, Rodie M, Sinnott R, Boroujerdi M, Lindhardt Johansen M, Hiort O, Holterhus PM, Cools M, Guaragna-Filho G, Guerra-Junior G, Weintrob N, Hannema S, Drop S, Guran T, Darendeliler F, Nordenstrom A, Hughes IA, Acerini C, Tadokoro-Cuccaro R, Ahmed SF (2016) The long-term outcome of boys with partial androgen insensitivity syndrome and a mutation in the androgen receptor gene. J Clin Endocrinol Metab 101(11):3959–3967. https://doi.org/10.1210/jc.2016-1372
Bouvattier C, Mignot B, Lefèvre H, Morel Y, Bougnères P (2006) Impaired sexual activity in male adults with partial androgen insensitivity. J Clin Endocrinol Metab 91(9):3310–3315. https://doi.org/10.1210/jc.2006-0218
Funding
This work was supported by MIUR-PRIN2017- 2017S9KTNE_003.
Author information
Authors and Affiliations
Contributions
EDP, SDC, FL, FP conceived the present study. EDP, SDC performed literature review and drafted the first version of the manuscript. FP, DP, AL and FL revised the final version. All Authors critically revised subsequent versions of the manuscript and approved the final version.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethics approval
No approval needed.
Research involving human participants and/or animals
No patient/animal was involved in the present research.
Consent to participate
Not applicable.
Consent for publication
All Authors give consent for publication.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Delli Paoli, E., Di Chiano, S., Paoli, D. et al. Androgen insensitivity syndrome: a review. J Endocrinol Invest 46, 2237–2245 (2023). https://doi.org/10.1007/s40618-023-02127-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40618-023-02127-y